Literature DB >> 24591859

A comparative study of folate and vitamin B12 serum levels in preeclamptic versus normotensive pregnant women in correlation with uterine and umbilical artery Doppler findings and pregnancy outcome.

Ahmed Mahmoud1, Eman A Elkattan1, Ashraf A Eldaly1, Eman F Omran1, Iman Mandour2.   

Abstract

OBJECTIVE: To detect the serum levels of folate and B12 in both preclamptic and normotensive pregnant women and to determine whether there is any relation between these levels with the uterine and umbilical artery Doppler indices as well as the pregnancy outcome.
MATERIAL AND METHODS: This case controlled study comprised 79 pregnant patients with preeclampsia and 113 healthy, normotensive pregnant women with singleton pregnancies at gestational ages ranging from 34-40 weeks. Patients were not obese (BMI<30) and did not suffer from chronic hypertension, chronic renal or liver disease nor diabetes mellitus. Serum folate and B12 were detected in all cases. They were also subjected to a Doppler study of both the uterine and umbilical arteries. Serum folate and B12 blood levels as well as the Doppler study indices (RI and PI) were compared in both groups.
RESULTS: The serum folate level was significantly lower in preeclamptic patients than normal pregnant women (p<0.001). It was significantly correlated to uterine artery Doppler indices (RI and PI) and negatively correlated to umbilical artery Doppler indices (RI and PI). Low serum folate was significantly correlated to poor maternal outcome. Low serum folate was also significantly correlated to poor perinatal outcome. Serum B12 level was not significantly different in preeclamptic patients from the control group (P value=0.14).
CONCLUSION: Serum folate was significantly lower in preeclamptic pregnant women with a significant correlation to increased uterine and umbilical RI, PI and poor maternal and neonatal outcome.

Entities:  

Keywords:  Preeclampsia; serum folate; serum vitamin B12; umbilical artery Doppler; uterine artery Doppler

Year:  2009        PMID: 24591859      PMCID: PMC3939119     

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  37 in total

1.  Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia.

Authors:  J Wang; B J Trudinger; N Duarte; D E Wilcken; X L Wang
Journal:  BJOG       Date:  2000-07       Impact factor: 6.531

2.  Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study.

Authors:  S Voutilainen; T H Rissanen; J Virtanen; T A Lakka; J T Salonen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

3.  Biophysical profile scores and resistance indices of the umbilical artery as seen in patients with pregnancy induced hypertension.

Authors:  S W Nguku; J Wanyoike-Gichuhi; A A Aywak
Journal:  East Afr Med J       Date:  2006-03

4.  Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation.

Authors:  Valerie A Holmes; Julie M W Wallace; H Denis Alexander; William S Gilmore; Ian Bradbury; Mary Ward; John M Scott; Peter McFaul; Helene McNulty
Journal:  Clin Chem       Date:  2004-12-22       Impact factor: 8.327

5.  Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia.

Authors:  Alan Buchbinder; Baha M Sibai; Steve Caritis; Cora Macpherson; John Hauth; Marshall D Lindheimer; Mark Klebanoff; Peter Vandorsten; Mark Landon; Richard Paul; Menachem Miodovnik; Paul Meis; Gary Thurnau
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

6.  Impact of pregnancy-induced hypertension on fetal growth.

Authors:  X Xiong; D Mayes; N Demianczuk; D M Olson; S T Davidge; C Newburn-Cook; L D Saunders
Journal:  Am J Obstet Gynecol       Date:  1999-01       Impact factor: 8.661

7.  The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy.

Authors:  Robert W Powers; Michael S Dunbar; Marcia J Gallaher; James M Roberts
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

8.  Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status.

Authors:  Wolfgang Herrmann; Sonia Isber; Rima Obeid; Markus Herrmann; Muhidien Jouma
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

Review 9.  Folate and carcinogenesis: an integrated scheme.

Authors:  S W Choi; J B Mason
Journal:  J Nutr       Date:  2000-02       Impact factor: 4.798

10.  Folate intake and the risk of neural tube defects: an estimation of dose-response.

Authors:  Lynn L Moore; M Loring Bradlee; Martha R Singer; Kenneth J Rothman; Aubrey Milunsky
Journal:  Epidemiology       Date:  2003-03       Impact factor: 4.822

View more
  4 in total

1.  Temporal expression of genes involved in folate metabolism and transport during placental development, preeclampsia and neural tube defects.

Authors:  Palani Selvam Mohanraj; Beenish Rahat; Aatish Mahajan; Rashmi Bagga; Jyotdeep Kaur
Journal:  Mol Biol Rep       Date:  2019-04-02       Impact factor: 2.316

2.  Iron, folate and vitamin B12 levels in first trimester pregnancies in the Southwest region of Turkey.

Authors:  Aysun Karabulut; Osman Sevket; Ayhan Acun
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-01

3.  Cross-sectional study of nutritional markers in pregnancy.

Authors:  Subhadra Sharma; Jai Bhagwan Sharma; Manisha Yadav; B R Usha; Sunesh Kumar; A K Mukhopadhyay
Journal:  Indian J Endocrinol Metab       Date:  2016 Nov-Dec

4.  Association of the folic acid consumption and its serum levels with preeclampsia in pregnant women.

Authors:  Hanieh Salehi-Pourmehr; Sakineh Mohamad-Alizadeh; Jamileh Malakouti; Azizeh Farshbaf-Khalili
Journal:  Iran J Nurs Midwifery Res       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.